Immediate-type hypersensitivity reaction to bulevirtide and successful desensitization in a patient with HBV/HDV-associated compensated cirrhosis-Reference-Cited by-同舟云学术

Immediate-type hypersensitivity reaction to bulevirtide and successful desensitization in a patient with HBV/HDV-associated compensated cirrhosis

Published:2022-07 Issue:1 Volume:77 Page:254-255
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Schwarz Caroline^ORCID,Chromy David^ORCID,Bangert Christine^ORCID,Schwarz Michael^ORCID,Jachs Mathias^ORCID,Reiberger Thomas,Gschwantler Michael

Publisher

Elsevier BV

Subject

Hepatology

Reference10 articles.

1. EMA. Hepcludex product information [Internet]. Available from: https://www.ema.europa.eu/en/documents/product-information/hepcludex-epar-product-information_en.pdf.

2. Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: first results of a phase Ib/IIa study;Bogomolov;J Hepatol,2016

3. Excellent safety and effectiveness of high-dose myrcludex-B monotherapy administered for 48 weeks in HDV-related compensated cirrhosis: a case report of 3 patients;Loglio;J Hepatol,2019

4. Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial;Wedemeyer;Lancet Infect Dis,2019

5. General considerations on rapid desensitization for drug hypersensitivity - a consensus statement;Cernadas;Allergy,2010

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Forgotten Virus, Hepatitis D: A Review of Epidemiology, Diagnosis, and Current Treatment Strategies;Journal of Clinical and Experimental Hepatology;2024-09

2. Antiviral Therapy of Chronic Hepatitis D Virus Infection – Addendum to the S3 Guideline “Prophylaxis, Diagnosis and Therapy of Hepatitis B Virus Infection” of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS);Zeitschrift für Gastroenterologie;2023-12

3. Addendum „Antivirale Therapie der chronischen Hepatitis-D-Virusinfektion“ zur S3-Leitlinie „Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS);Zeitschrift für Gastroenterologie;2023-12

4. Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppression;JHEP Reports;2023-08

5. EASL Clinical Practice Guidelines on hepatitis delta virus;Journal of Hepatology;2023-08